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ABSTRACT
The COVID-19 pandemic has led to significant morbidity 
and mortality globally. As health systems grapple with 
caring for patients affected with COVID-19, cardiovascular 
procedures that are deemed ‘elective’ have been 
postponed. Guidelines concerning which cardiac 
procedures should be performed during the pandemic 
vary by specialty and geography in the USA. We propose 
a clinical heuristic to guide individual physicians and 
governing bodies in their decision making regarding 
which cardiac procedures should be performed during 
the COVID-19 pandemic using the behavioural economics 
concept of heuristics and ecological rationality.
COVID-19 AND CARDIOVASCULAR MEDICINE
Chinese healthcare officials described a novel 
coronavirus in December 2019 (COVID-19) 
that was responsible for an acute respira-
tory illness, leading to death in 3%–4% of 
cases to date.1 In the following months, the 
coronavirus outbreak was declared a global 
pandemic by the WHO, and the number of 
cases in the USA continued to rise.2 As of 
this writing, over 25 million confirmed cases 
have been reported globally, of which 843 238 
affected individuals have died of COVID-19- 
related illnesses.3
The response of the cardiovascular (CV) 
community across the world has been brisk. 
Although COVID-19 has been reported to 
cause myocardial injury and even fulminant 
myocarditis, the majority of COVD-19- related 
mortality is driven by pulmonary injury partic-
ularly in elderly populations.4 In light of these 
growing clinical concerns, hospitals across the 
USA and the world were faced with the chal-
lenge of restricting access to some forms of 
CV care. CV care delivery in both outpatient, 
office- based settings and inpatients settings 
has been affected. One example of this is the 
cancellation of ‘elective’ CV procedures. On 
18 March 2020, the Centers for Medicare & 
Medicaid Services (CMS), the federal agency 
that sets US healthcare policy and reimburse-
ment regulations, announced that all elective 
surgeries and medical and dental procedures 
would be postponed during the COVID-19 
pandemic largely due to the need to restrict 
the non- urgent use of personal protective 
equipment.5 6
TRAGIC CHOICES IN THE ERA OF COVID-19
In their 1978 classic work Tragic Choices, Cala-
bresi and Bobbitt describe how under extraor-
dinary circumstances, society is forced to make 
difficult choices on deriving from a scarcity of 
goods and services.7 Tragic choices arise from 
the conflicts that arise when a society is forced 
to decide who benefits from the distribution 
of resources in austere environments of scar-
city and that society’s inherent moral values. 
Calabresi and Bobbitt, both economists and 
legal scholars, go on to state, ‘The object of 
public policy must be, therefore, to define 
with respect to each particular tragic choice, 
that combination of approaches which most 
limits tragedy and which deals with that irre-
ducible minimum in the least offensive way’. 
Viewed then through the lens of healthcare 
policy, the painful choices facing the global 
medical community during the current 
COVID-19 outbreak are striking, yet in some 
circumstances, unavoidable.
On 16 March 2020, the Società Italiana Di 
Anestesia Analgesia Rianimazione E Terapia 
Intensiva released an urgent publication enti-
tled ‘Clinical Ethics Recommendations for 
the Allocation of Intensive Care Treatments, 
In Exceptional, Resource- Limited Circum-
stances’.8 In this telling document, a group of 
experts from their respective medical society 
outlined the potential need for specifying the 
allocation of scarce healthcare resources in 
the face of the COVID-19 outbreak. These 
measures include potentially defining an age 
limit for admission to the intensive care unit, 
withholding invasive mechanical ventilation 
and maximising the benefits of resource allo-
cation for the greatest number of patients. 
These recommendations mirror guidelines 
invoked during wartime or disaster medicine 
typified by extreme limitations to the access 
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DEFINING ELECTIVE CV PROCEDURES AND THEIR CLINICAL 
ECOSYSTEMS
Despite a uniform desire within the CV community to 
support vigorous efforts in the fight against COVID-19, 
heterogeneous opinions were proposed as to which CV 
procedures should be deemed elective. The American 
College of Surgeons (ACS) released clinician guidelines 
concerning those surgical procedures that should be 
delayed during the COVID-19 outbreak.9 Importantly, 
the ACS emphasises the role of the surgeon’s expertise in 
making a determination as to the necessity of proceeding 
with surgery during these extraordinary times. Emanating 
from these recommendations was a procedural frame-
work created by clinicians in St Louis, MO. that desig-
nated the Elective Surgery Acuity Scale (ESAS). Following 
the dissemination of the ESAS framework, the CMS 
adopted and amended this tiered framework to include 
broad classifications of CV procedures.5
Across the USA, elective cardiac procedures are 
performed in a wide variety of settings including ambula-
tory care facilities, outpatient surgical centres and tradi-
tional hospital settings. Each of these clinical venues differ 
in its respective exposure to caring for patients either 
exposed to or infected with COVID-19. Consequently, 
the decision to perform an elective cardiac procedure 
impacts multiple stakeholders. The patient undergoing 
treatment is expected to benefit from it, but in so doing, 
may be exposed to COVID-19 from the clinical environ-
ment of care. Likewise, 40%–50% of all patients infected 
with COVID-19 but not yet exhibiting symptoms may serve 
as a vector to other patients or providers within a clinical 
ecosystem. Additionally, elective patients may consume 
vital healthcare material and/or human resources that 
would be better allocated to sicker patients as supply 
chain management becomes an increasing concern 
among hospitals and clinics.
Given the broad discretion encompassed within the 
CMS tiered framework, some US health systems continued 
to proceed with elective CV procedures while others 
restricted them. This heterogeneity has led to confusion 
among some CV caregivers as to which procedures should 
be performed and which should be deferred. The US 
healthcare system largely relies on a fee- for- service reim-
bursement model at both practitioner and facility levels. 
Thus, the financial and economic impact of elective proce-
dure cancellations may be substantial and uneven across 
US healthcare delivery systems.10 The business survival of 
many healthcare systems, normally supported by elective 
surgeries and procedures, has been placed at real risk. 
This represents yet another valid reason health systems 
and clinicians alike sought clarification from the US 
federal government and professional societies regarding 
which procedures should proceed and which should be 
postponed. Fortunately, several major US CV professional 
societies offered practitioners better guidance for which 
procedures should and should not be delayed during the 
COVID-19 crisis.11–13
Beyond financial concerns, the impact of the COVID-19 
pandemic on clinical outcomes is only now beginning to 
be realised. Early reports of significantly lower hospital-
isations for common CV conditions such as acute myocar-
dial infarction and higher rates of out of hospital cardiac 
arrest suggest a potential avoidance of care on the part 
of patients owing to reduced caregiver access or fear 
of acquiring COVID-19 in- hospital.14–18 These aversion 
behaviours may ultimately lead to greater CV morbidity 
and mortality than during similar historical time periods. 
Coupled with reduced hospitalisation rates would be 
a decline in appropriate CV procedural activity. For 
example, a review of diagnostic cardiac catheterisation 
volumes occurring within a large consortium of tertiary 
care cardiac centres revealed a significant reduction in 
procedural volumes when compared with prior years’ 
data.15 Thus, the COVID-19 pandemic has created an 
environment of uncertainty on the part of patients and 
clinicians alike. These uncertainties may unfortunately 
lead to poorer long- term clinical outcomes, worsened 
health system financial positions and erosion of patient 
confidence in entering healthcare facilities.
TOWARDS A SIMPLIFIED DECISION-MAKING TOOL FOR CV 
CLINICIANS CONSIDERING ‘ELECTIVE’ CV PROCEDURES
The guidance of specialty- specific professional societies 
is invaluable to practising CV clinicians in these uncer-
tain times. Although helpful, the clinical scenarios 
confronting cardiology specialists at healthcare systems 
across the USA during the pandemic remained highly 
variable. Increasingly, CV physicians were forced to weigh 
the pros and cons of proceeding with not only elective 
cardiac procedures but in some instances, outpatient 
preprocedural consultation also.
In light of these findings, we propose a simplified, 
yet widely applicable heuristic to aid clinicians in their 
medical decision- making process in these times of height-
ened uncertainty. Heuristics are decision- support tools 
that have been well described in the psychological and 
behavioural economics literature. During the COVID-19 
crisis, medical decision making in healthcare has been 
increasingly being made under uncertainty. Incomplete 
information leads to diagnostic ambiguities that render 
treatment decisions more difficult.19 As such, our frame-
work for creating care plans may be viewed as occurring 
with the environment of ecological rationality as advo-
cated by Gigerenzer.20 21 Within the domain of ecological 
rationality, heuristics serve individuals to function within 
a dynamic environment, an environment that may or may 
not be rational in the classical sense. As the COVID-19 
pandemic has resulted in global tumult, simple heuristics 
may be of help to practising clinicians in allocating CV 
services while functioning in an ‘irrational’ environment.
Consequently, we propose the following heuristic to be 
considered during the ongoing pandemic: clinicians may 
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with clinical guidelines after discussion with patients if all 
of the following conditions are met5 :
 ► The procedure may take place in a clinical environ-
ment commensurate with usual care if the patient 
meets conventional clinical indications for that proce-
dure following appropriate diagnostic evaluation in 
an environment that minimises the risk of infection.
 ► Neither the patient nor any member of the proce-
dural team is actively infected with COVID-19.
 ► By performing the procedure, the patient and care 
team will consume fewer total healthcare resources 
than they would if the procedure had not been 
performed.
 ► Procedural performance will not overtly disadvantage 
a sicker patient in the immediate respective clinical 
environment.
Cognizant of the potential for unintentional selection 
bias inherent when clinicians are forced to prioritise 
and allocate precious and scarce human and material 
resources, it could be considered that the decision to 
proceed with elective CV procedures could be vetted by a 
local multidisciplinary CV care team, thereby supporting 
the individual physician’s decision to proceed or delay 
care. Further, clinicians opting to proceed with elec-
tive CV procedures should be mindful of that patient’s 
non- cardiac comorbidities and the potential for creating 
a need for the involvement of other non- CV specialists 
whose capacity to support that patient’s needs may strain 
their capacity to care for other, sicker patients. Although 
the long- term effects of the COVID-19 pandemic on clin-
ical cardiac outcomes remain unknown, a strategy aimed 
at unifying clinical decision making across and within 
complex and highly variable care environments via using 
heuristics may help preserve high- quality CV care and 
measurable patient outcomes during times of unprece-
dented uncertainty.22
We acknowledge that no heuristic framework is perfect, 
and we recognise that individual caregivers and health 
systems have been forced to make difficult decisions under 
dynamic conditions conferring substantial uncertainty. 
Similar to our Italian colleagues, extraordinary decisions 
may have to be made that defy our usual customs. None-
theless, we believe that having created an easily applied 
heuristic may be of benefit to other frontline caregivers 
who struggled with making the decision on how best to 
deliver CV care to patients in need during exceptionally 
difficult times.
CONCLUSIONS
The COVID-19 pandemic has placed an extraordinary 
strain on the global healthcare delivery system. CV 
caregivers have struggled with medical decision making 
in many instances during these uncertain times. In 
our experiences, clinical heuristics developed for elec-
tive CV procedures within what can be regarded as an 
environment of ecological rationality may afford CV 
clinicians with additional tools helped us manage the 
tragic choices presented by COVID-19 while minimising 
what could be tragic outcomes to our patients, staff and 
population.
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